Incidens, patologi og klinik ved neuroendokrine gastrointestinale tumorer

Birgitte Hartnack Federspiel; Carsten Palnaes Hansen; Ben Vainer; Jane Preuss Hasselby; Linda Bardram; Ulrich Knigge

Incidens, patologi og klinik ved neuroendokrine gastrointestinale tumorer

Birgitte Hartnack Federspiel, Carsten Palnaes Hansen, Ben Vainer, Jane Preuss Hasselby, Linda Bardram, Ulrich Knigge

1 Citationer (Scopus)

Abstract

Gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) are unusual. Their incidence, the different tumour types and growth patterns are described. The tumours should be classified according to the WHO 2000 classification and the Tumour Node Metastasis classification according to guidelines from the European Neuroendocrine Tumour Society. Important parameters are localization, size, hormonal secretion, mitotic index, and proliferation index (Ki-67) of the primary tumour. Patients with GEP NET should be referred to as few centres as possible in order to obtain the highest experience and the greatest understanding of these tumours thereby achieving the capacity to offer patients the best possible treatment and to create optimal conditions for research.

Bidragets oversatte titel	[Incidence, pathology and clinical course and symptoms of neuroendocrine gastrointestinal tumours]
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	172
Udgave nummer	43
Sider (fra-til)	2946-50
Antal sider	5
ISSN	0041-5782
Status	Udgivet - 25 okt. 2010

Citationsformater

@article{0cefc7aca76e42cca25ddfba8cc79b01,

title = "Incidens, patologi og klinik ved neuroendokrine gastrointestinale tumorer",

abstract = "Gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) are unusual. Their incidence, the different tumour types and growth patterns are described. The tumours should be classified according to the WHO 2000 classification and the Tumour Node Metastasis classification according to guidelines from the European Neuroendocrine Tumour Society. Important parameters are localization, size, hormonal secretion, mitotic index, and proliferation index (Ki-67) of the primary tumour. Patients with GEP NET should be referred to as few centres as possible in order to obtain the highest experience and the greatest understanding of these tumours thereby achieving the capacity to offer patients the best possible treatment and to create optimal conditions for research.",

author = "Federspiel, {Birgitte Hartnack} and Hansen, {Carsten Palnaes} and Ben Vainer and Hasselby, {Jane Preuss} and Linda Bardram and Ulrich Knigge",

year = "2010",

month = oct,

day = "25",

language = "Dansk",

volume = "172",

pages = "2946--50",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "43",

}

TY - JOUR

T1 - Incidens, patologi og klinik ved neuroendokrine gastrointestinale tumorer

AU - Federspiel, Birgitte Hartnack

AU - Hansen, Carsten Palnaes

AU - Vainer, Ben

AU - Hasselby, Jane Preuss

AU - Bardram, Linda

AU - Knigge, Ulrich

PY - 2010/10/25

Y1 - 2010/10/25

N2 - Gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) are unusual. Their incidence, the different tumour types and growth patterns are described. The tumours should be classified according to the WHO 2000 classification and the Tumour Node Metastasis classification according to guidelines from the European Neuroendocrine Tumour Society. Important parameters are localization, size, hormonal secretion, mitotic index, and proliferation index (Ki-67) of the primary tumour. Patients with GEP NET should be referred to as few centres as possible in order to obtain the highest experience and the greatest understanding of these tumours thereby achieving the capacity to offer patients the best possible treatment and to create optimal conditions for research.

AB - Gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) are unusual. Their incidence, the different tumour types and growth patterns are described. The tumours should be classified according to the WHO 2000 classification and the Tumour Node Metastasis classification according to guidelines from the European Neuroendocrine Tumour Society. Important parameters are localization, size, hormonal secretion, mitotic index, and proliferation index (Ki-67) of the primary tumour. Patients with GEP NET should be referred to as few centres as possible in order to obtain the highest experience and the greatest understanding of these tumours thereby achieving the capacity to offer patients the best possible treatment and to create optimal conditions for research.

M3 - Tidsskriftartikel

SN - 0041-5782

VL - 172

SP - 2946

EP - 2950

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 43

ER -

Incidens, patologi og klinik ved neuroendokrine gastrointestinale tumorer

Abstract

Fingeraftryk

Citationsformater